This Company's Entertainment Bundles Could Lead to Higher Dividends

Don’t want emails from us anymore? Click here to unsubscribe.

Hello and welcome to Dividend Brief, the 2 times weekly newsletter focused on dividend investing.

Today, we will look into Novo Nordisk, Comcast, and Oracle, highlight a few dividend stocks worth watching, as well as share companies that are about to pay a dividend in the next few days.

Don’t Miss This Alert

This NASDAQ Stock Could Make Waves on Jan 30th

A game-changing alert is on the horizon, and it’s one you can’t afford to miss.

A small-cap NASDAQ company, fresh off a string of bold acquisitions, is setting the stage for a potential breakout.

With Wall Street starting to take notice, all eyes are on January 30th for what could be a massive move.

(By clicking the link above, you agree to receive emails from Huge Alerts. You can opt out at any time. - Privacy Policy)

Don’t let this opportunity slip by.

Click here to secure your spot and get the alert first.

(By clicking the link above, you agree to receive emails from Huge Alerts. You can opt out at any time. - Privacy Policy)

Healthcare

Novo Nordisk Reports Positive Trial Results for Obesity Treatment

Novo Nordisk has shared new insights from an early-stage clinical trial evaluating amycretin, a dual GLP-1 and amylin receptor agonist, designed for weekly subcutaneous use. The trial examined the therapy’s safety, tolerability, pharmacokinetics, and potential effects on individuals with overweight or obesity.

Spanning multiple stages, the study included single and multiple dose escalation trials and a dose-response assessment over a treatment period of up to 36 weeks. Participants received varying maintenance doses, while researchers closely monitored for adverse events, which were primarily gastrointestinal in nature and mostly mild to moderate.

The results demonstrated promising outcomes, with notable reductions in body weight among participants adhering to the treatment regimen. These findings build on the potential of amycretin as a weight-loss therapy, complementing earlier research into its oral formulation.

With these encouraging results, Novo Nordisk plans to advance the clinical development of amycretin, focusing on its role in managing weight and potentially supporting adults with type 2 diabetes. Both oral and subcutaneous options are being developed to offer flexible treatment solutions.

This trial underscores the growing interest in innovative treatments aimed at addressing the global challenges of obesity and related conditions. Further studies will refine amycretin’s therapeutic potential and its broader application in healthcare.

NVO currently trades at $81 and pays a dividend of 36 cents per share, a yield of 1.78%.

Entertainment

Comcast Introduces Sports and News Streaming Bundle

Comcast has introduced a new streaming bundle designed for sports and news enthusiasts. Priced at $70 per month, the "Sports & News TV" package offers live coverage of major leagues like the NFL, NBA, NHL, MLB, and NCAA, alongside access to over 50 news and sports channels, including ABC, CBS, NBC, Fox, ESPN, and CNN. This initiative is part of a growing effort to enhance the sports streaming landscape.

The bundle also includes Peacock, 300 hours of cloud DVR storage, and access to more than 100 free streaming channels. While it doesn’t require an Xfinity TV box, using one unlocks additional features such as multiview, enhanced 4K options, and integrated sports betting odds. Subscribers can also access the bundle through the Xfinity Stream app on mobile devices and platforms like Roku and Apple TV.

This package can be paired with Comcast’s additional offerings, such as a $9.95 add-on featuring premium sports channels like NFL RedZone and NBA TV. Meanwhile, competitors like DirecTV have introduced similar sports bundles, showcasing an evolving market for live sports streaming as traditional cable alternatives continue to grow in popularity.

CMCSA currently trades at $37 and pays a dividend of 31 cents per share, a yield of 3.36%.

Aerospace

[Pre-IPO Alert] Under-the-Radar Space Stock Backed by NASA

The space economy is expected to exceed $1 trillion in the coming years, and one overlooked company is quietly positioning itself as a key player in this booming sector.

By focusing on two untapped niches—hypersonic missile testing and micro-satellite launching—this innovative company has created a dual-growth model that could drive massive revenues.

(By clicking the link above, you agree to receive emails from Bullish Bear. You can opt out at any time. - Privacy Policy)

It already collaborates with aerospace giants like Lockheed Martin and Northrop Grumman while operating from NASA’s Kennedy Space Center.

With billions being poured into hypersonic missile development and surging demand for satellite launches, the stage is set for this company to soar.

Early investors have the rare opportunity to get in at under $4 per share through a special pre-IPO offering.

Click here to learn more and secure your spot in this groundbreaking venture.

(By clicking the link above, you agree to receive emails from Bullish Bear. You can opt out at any time. - Privacy Policy)

Tech

Oracle Partners with SoftBank and OpenAI to Expand Cloud Business

Oracle has entered 2025 with strong momentum, building on a standout year and signaling ambitious plans to grow its cloud computing presence. A major joint venture with SoftBank and OpenAI, valued at $100 billion, aims to expand Oracle's data centers and bolster its competitive position in the cloud market, where it trails larger players like Amazon and Microsoft. This initiative aligns with the broader push to integrate artificial intelligence across industries, sparking optimism about Oracle’s growth potential.

Despite its relatively small market share in cloud infrastructure, Oracle's collaboration could accelerate revenue growth, with some estimates projecting significant expansion over the next few years. However, questions remain about the scope of these new commitments and whether they represent a meaningful shift beyond previously announced initiatives.

While Oracle's stock has seen impressive gains, analysts are approaching the news with caution, citing uncertainty about the timeline and impact of the projects. The company’s shares have surged in early January, following a remarkable performance last year, but concerns about valuation persist.

Oracle’s cloud infrastructure division is expected to see stronger growth compared to overall revenue, signaling optimism for its long-term trajectory. However, many are waiting for concrete results before fully embracing the company’s ambitious plans.

ORCL currently trades at $185 and pays a dividend of 40 cents per share, a yield of 0.86%.

2025 Stock Picks

10 Best Stocks to Own in 2025

As 2025 approaches, finding reliable stocks that offer both growth and steady income is more important than ever.

A new report, "10 Best Stocks to Own in 2025," highlights well-established companies that combine long-term growth potential with consistent dividend payouts.

By clicking the link above, you will get this free report and a free subscription to MarketBeat's daily email newsletter. You are also agreeing to the terms of our privacy policy. Unsubscribe at any time.)

These stocks are designed to help investors navigate uncertain markets while building wealth over time.

Whether you’re planning for retirement or looking to enhance your portfolio, this is your chance to align with companies poised for success in the coming years.

Click here to access your free copy and see the top picks for 2025.

(By clicking the link above, you will get this free report and a free subscription to MarketBeat's daily email newsletter. You are also agreeing to the terms of our privacy policy. Unsubscribe at any time.)

Everything Else